The American Journal of Managed Care5 小时
Resveratrol Oral Supplement Associated With Lower Rates of Intravitreal Aflibercept Injections
Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...
Opthea Limited: Promising Outlook with Sozinibercept in wAMD and Pivotal Trials on Track
Leerink Partners analyst Marc Goodman has maintained their bullish stance on OPT stock, giving a Buy rating yesterday.Invest with Confidence: ...
Dry AMD: SeaBeLife achieves highly promising preclinical efficacy results for SBL03 ...
SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...
来自MSN17 小时
Broker Upgrades: Canaccord says disease specialist Opthea could triple if Phase III trial ...
Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as ... Read More The ...
unr.edu20 小时
How light could transform eye health
The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...